Dr.Reddy's Laboratories Ltd (NYSE:RDY)

51.15
Data as of Oct 24
 +0.58 / +1.15%
Today’s Change
38.00
Today|||52-Week Range
53.67
+24.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$8.6B

Company Description

Dr. Reddy's Laboratories Ltd. is a global pharmaceutical company that manufactures and markets pharmaceutical products. It operates through three business segments which include Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products. The Pharmaceutical Services & Active Ingredients segment consists of its Active Pharmaceutical Ingredients business and Custom Pharmaceutical Services business. It also includes contract research services and the manufacture and sale of active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Global Generics segment consists of finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). It includes the operations of the company's biologics business. The Proprietary Products segment involves the discovery of new chemical entities and differentiated formulations for subsequent commercialization and out-licensing. The company's differentiated formulations portfolio consists of new, synergistic combinations and technologies that improve safety and/or efficacy by modifying pharmacokinetics of existing medicines. It also involves the company's specialty pharmaceuticals business, which conducts sales and marketing operations for in-licensed and co-developed dermatology products. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Contact Information

Dr. Reddy's Laboratories Ltd.
Door No. 8-2-337
Hyderabad Andhra Pradesh 500034
P:914049002900
Investor Relations:
914066834297

Employees

Shareholders

Mutual fund holders5.30%
Other institutional11.81%
Individual stakeholders--

Top Executives

Gunupati Venkateswara PrasadCo-Chairman, Chief Executive Officer & MD
Saumen ChakrabortyPresident, CFO & Global Head-Human Resources
Abhijit MukherjeeChief Operating Officer
Umang VohraEVP & Head-North America Generics Business
Samiran DasEVP & Head-Formulations Technical Operations

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.